May 30, 2011 / 9:58 PM / 9 years ago

Bayer to outsource Betaferon production - report

FRANKFURT (Reuters) - Bayer (BAYGn.DE) will outsource production of its blockbuster drug Betaferon to its rival Boehringer Ingelheim, Financial Times Deutschland said in an advance copy of its Tuesday edition.

Production in Emeryville will be shut down in 2013, resulting in the loss of around 540 jobs, the report said, citing the company.

Bayer officials could not be reached for comment.

Reporting by Edward Taylor; Editing by Dan Grebler

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below